This suggests that dietary composition alone may not be sufficient to regulate eNOS expression, in keeping with the idea that additional metabolic disturbances (obesity, inflammation, and hypoxia) play contributing roles. The gene discussed is NOS3; the disease is obesity due to melanocortin 4 receptor deficiency.